nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.11	0.197	CbGbCtD
Nabumetone—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.103	0.185	CbGbCtD
Nabumetone—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.103	0.185	CbGbCtD
Nabumetone—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0935	0.167	CbGbCtD
Nabumetone—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0784	0.14	CbGbCtD
Nabumetone—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0709	0.127	CbGbCtD
Nabumetone—MPO—saliva—acquired immunodeficiency syndrome	0.0125	0.157	CbGeAlD
Nabumetone—MPO—endothelium—acquired immunodeficiency syndrome	0.00613	0.0772	CbGeAlD
Nabumetone—MPO—blood plasma—acquired immunodeficiency syndrome	0.00545	0.0686	CbGeAlD
Nabumetone—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00298	0.0375	CbGeAlD
Nabumetone—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00291	0.0366	CbGeAlD
Nabumetone—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00278	0.035	CbGeAlD
Nabumetone—MPO—skin of body—acquired immunodeficiency syndrome	0.00262	0.033	CbGeAlD
Nabumetone—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00258	0.0325	CbGeAlD
Nabumetone—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00247	0.0311	CbGeAlD
Nabumetone—MPO—lymphoid tissue—acquired immunodeficiency syndrome	0.00212	0.0267	CbGeAlD
Nabumetone—MPO—digestive system—acquired immunodeficiency syndrome	0.00209	0.0264	CbGeAlD
Nabumetone—MPO—blood—acquired immunodeficiency syndrome	0.002	0.0251	CbGeAlD
Nabumetone—MPO—bone marrow—acquired immunodeficiency syndrome	0.00193	0.0243	CbGeAlD
Nabumetone—MPO—spinal cord—acquired immunodeficiency syndrome	0.00192	0.0242	CbGeAlD
Nabumetone—MPO—lung—acquired immunodeficiency syndrome	0.00175	0.022	CbGeAlD
Nabumetone—MPO—nervous system—acquired immunodeficiency syndrome	0.00162	0.0204	CbGeAlD
Nabumetone—MPO—central nervous system—acquired immunodeficiency syndrome	0.00156	0.0196	CbGeAlD
Nabumetone—PTGS1—skin of body—acquired immunodeficiency syndrome	0.00124	0.0156	CbGeAlD
Nabumetone—MPO—brain—acquired immunodeficiency syndrome	0.00124	0.0156	CbGeAlD
Nabumetone—MPO—lymph node—acquired immunodeficiency syndrome	0.0012	0.0151	CbGeAlD
Nabumetone—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00119	0.0149	CbGeAlD
Nabumetone—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00115	0.0144	CbGeAlD
Nabumetone—CYP1A2—blood—acquired immunodeficiency syndrome	0.00109	0.0137	CbGeAlD
Nabumetone—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000994	0.0125	CbGeAlD
Nabumetone—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000962	0.0121	CbGeAlD
Nabumetone—CYP1A2—lung—acquired immunodeficiency syndrome	0.000958	0.0121	CbGeAlD
Nabumetone—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00095	0.012	CbGeAlD
Nabumetone—PTGS1—blood—acquired immunodeficiency syndrome	0.000947	0.0119	CbGeAlD
Nabumetone—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000912	0.0115	CbGeAlD
Nabumetone—PTGS2—blood—acquired immunodeficiency syndrome	0.000905	0.0114	CbGeAlD
Nabumetone—PTGS1—vagina—acquired immunodeficiency syndrome	0.000878	0.011	CbGeAlD
Nabumetone—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000876	0.011	CbGeAlD
Nabumetone—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000872	0.011	CbGeAlD
Nabumetone—PTGS2—vagina—acquired immunodeficiency syndrome	0.000839	0.0106	CbGeAlD
Nabumetone—PTGS1—lung—acquired immunodeficiency syndrome	0.00083	0.0104	CbGeAlD
Nabumetone—PTGS2—lung—acquired immunodeficiency syndrome	0.000793	0.00998	CbGeAlD
Nabumetone—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000769	0.00967	CbGeAlD
Nabumetone—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.00074	0.00931	CbGeAlD
Nabumetone—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000735	0.00924	CbGeAlD
Nabumetone—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000707	0.0089	CbGeAlD
Nabumetone—PTGS1—brain—acquired immunodeficiency syndrome	0.000587	0.00739	CbGeAlD
Nabumetone—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000568	0.00714	CbGeAlD
Nabumetone—PTGS2—brain—acquired immunodeficiency syndrome	0.000562	0.00707	CbGeAlD
Nabumetone—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000543	0.00683	CbGeAlD
Nabumetone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000309	0.000858	CcSEcCtD
Nabumetone—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.000857	CcSEcCtD
Nabumetone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000308	0.000853	CcSEcCtD
Nabumetone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000308	0.000852	CcSEcCtD
Nabumetone—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.000852	CcSEcCtD
Nabumetone—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.000852	CcSEcCtD
Nabumetone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000307	0.000851	CcSEcCtD
Nabumetone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000307	0.000851	CcSEcCtD
Nabumetone—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.000847	CcSEcCtD
Nabumetone—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.000847	CcSEcCtD
Nabumetone—Rash—Didanosine—acquired immunodeficiency syndrome	0.000305	0.000845	CcSEcCtD
Nabumetone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000305	0.000845	CcSEcCtD
Nabumetone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000305	0.000845	CcSEcCtD
Nabumetone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000305	0.000845	CcSEcCtD
Nabumetone—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.000841	CcSEcCtD
Nabumetone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000303	0.00084	CcSEcCtD
Nabumetone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000303	0.000839	CcSEcCtD
Nabumetone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000302	0.000838	CcSEcCtD
Nabumetone—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.000837	CcSEcCtD
Nabumetone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.000836	CcSEcCtD
Nabumetone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000302	0.000836	CcSEcCtD
Nabumetone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000301	0.000835	CcSEcCtD
Nabumetone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000301	0.000834	CcSEcCtD
Nabumetone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.000833	CcSEcCtD
Nabumetone—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.000833	CcSEcCtD
Nabumetone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.000832	CcSEcCtD
Nabumetone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.000832	CcSEcCtD
Nabumetone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.00083	CcSEcCtD
Nabumetone—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000299	0.000829	CcSEcCtD
Nabumetone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000299	0.000828	CcSEcCtD
Nabumetone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.000827	CcSEcCtD
Nabumetone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000298	0.000826	CcSEcCtD
Nabumetone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000298	0.000825	CcSEcCtD
Nabumetone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000297	0.000823	CcSEcCtD
Nabumetone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000297	0.000823	CcSEcCtD
Nabumetone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000297	0.000822	CcSEcCtD
Nabumetone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.000821	CcSEcCtD
Nabumetone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000295	0.000818	CcSEcCtD
Nabumetone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.000818	CcSEcCtD
Nabumetone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000295	0.000818	CcSEcCtD
Nabumetone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.000815	CcSEcCtD
Nabumetone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000293	0.000811	CcSEcCtD
Nabumetone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000293	0.000811	CcSEcCtD
Nabumetone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.000811	CcSEcCtD
Nabumetone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.000811	CcSEcCtD
Nabumetone—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.000809	CcSEcCtD
Nabumetone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000292	0.000809	CcSEcCtD
Nabumetone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00029	0.000805	CcSEcCtD
Nabumetone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.000804	CcSEcCtD
Nabumetone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00029	0.000804	CcSEcCtD
Nabumetone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.000802	CcSEcCtD
Nabumetone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.000801	CcSEcCtD
Nabumetone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000289	0.0008	CcSEcCtD
Nabumetone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000289	0.0008	CcSEcCtD
Nabumetone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000288	0.000799	CcSEcCtD
Nabumetone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.000798	CcSEcCtD
Nabumetone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.000798	CcSEcCtD
Nabumetone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000287	0.000796	CcSEcCtD
Nabumetone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000287	0.000796	CcSEcCtD
Nabumetone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.000795	CcSEcCtD
Nabumetone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.000794	CcSEcCtD
Nabumetone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.000793	CcSEcCtD
Nabumetone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.000792	CcSEcCtD
Nabumetone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.000792	CcSEcCtD
Nabumetone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00079	CcSEcCtD
Nabumetone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.000787	CcSEcCtD
Nabumetone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.000786	CcSEcCtD
Nabumetone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000283	0.000785	CcSEcCtD
Nabumetone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.000782	CcSEcCtD
Nabumetone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00078	CcSEcCtD
Nabumetone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.000778	CcSEcCtD
Nabumetone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00028	0.000775	CcSEcCtD
Nabumetone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.000774	CcSEcCtD
Nabumetone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.000773	CcSEcCtD
Nabumetone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.000772	CcSEcCtD
Nabumetone—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.000772	CcSEcCtD
Nabumetone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000279	0.000772	CcSEcCtD
Nabumetone—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00077	CcSEcCtD
Nabumetone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000278	0.00077	CcSEcCtD
Nabumetone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000278	0.000769	CcSEcCtD
Nabumetone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.000769	CcSEcCtD
Nabumetone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000277	0.000766	CcSEcCtD
Nabumetone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000277	0.000766	CcSEcCtD
Nabumetone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.000764	CcSEcCtD
Nabumetone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.000763	CcSEcCtD
Nabumetone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00076	CcSEcCtD
Nabumetone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00076	CcSEcCtD
Nabumetone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.00076	CcSEcCtD
Nabumetone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.000759	CcSEcCtD
Nabumetone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.000758	CcSEcCtD
Nabumetone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000274	0.000758	CcSEcCtD
Nabumetone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.000757	CcSEcCtD
Nabumetone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.000756	CcSEcCtD
Nabumetone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000273	0.000755	CcSEcCtD
Nabumetone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.000751	CcSEcCtD
Nabumetone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00075	CcSEcCtD
Nabumetone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.000749	CcSEcCtD
Nabumetone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00027	0.000747	CcSEcCtD
Nabumetone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.000745	CcSEcCtD
Nabumetone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.000744	CcSEcCtD
Nabumetone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000268	0.000744	CcSEcCtD
Nabumetone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000268	0.000744	CcSEcCtD
Nabumetone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000268	0.000742	CcSEcCtD
Nabumetone—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000741	CcSEcCtD
Nabumetone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000267	0.00074	CcSEcCtD
Nabumetone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.000739	CcSEcCtD
Nabumetone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.000737	CcSEcCtD
Nabumetone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000266	0.000736	CcSEcCtD
Nabumetone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000265	0.000735	CcSEcCtD
Nabumetone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000265	0.000734	CcSEcCtD
Nabumetone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.000733	CcSEcCtD
Nabumetone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000265	0.000733	CcSEcCtD
Nabumetone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.000733	CcSEcCtD
Nabumetone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.000732	CcSEcCtD
Nabumetone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000264	0.000731	CcSEcCtD
Nabumetone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000263	0.000729	CcSEcCtD
Nabumetone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000263	0.000729	CcSEcCtD
Nabumetone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.000728	CcSEcCtD
Nabumetone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.000727	CcSEcCtD
Nabumetone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.000727	CcSEcCtD
Nabumetone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000262	0.000726	CcSEcCtD
Nabumetone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000261	0.000723	CcSEcCtD
Nabumetone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000261	0.000722	CcSEcCtD
Nabumetone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.000722	CcSEcCtD
Nabumetone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.000722	CcSEcCtD
Nabumetone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000722	CcSEcCtD
Nabumetone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000259	0.000718	CcSEcCtD
Nabumetone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.000716	CcSEcCtD
Nabumetone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.000716	CcSEcCtD
Nabumetone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.000711	CcSEcCtD
Nabumetone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00071	CcSEcCtD
Nabumetone—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000707	CcSEcCtD
Nabumetone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.000706	CcSEcCtD
Nabumetone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.000706	CcSEcCtD
Nabumetone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.000703	CcSEcCtD
Nabumetone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.000703	CcSEcCtD
Nabumetone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.000701	CcSEcCtD
Nabumetone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.000701	CcSEcCtD
Nabumetone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.000699	CcSEcCtD
Nabumetone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.000698	CcSEcCtD
Nabumetone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.000695	CcSEcCtD
Nabumetone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.000693	CcSEcCtD
Nabumetone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00025	0.000693	CcSEcCtD
Nabumetone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.000692	CcSEcCtD
Nabumetone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00025	0.000692	CcSEcCtD
Nabumetone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000249	0.000691	CcSEcCtD
Nabumetone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000688	CcSEcCtD
Nabumetone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.000685	CcSEcCtD
Nabumetone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.000684	CcSEcCtD
Nabumetone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000246	0.000681	CcSEcCtD
Nabumetone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00068	CcSEcCtD
Nabumetone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.000678	CcSEcCtD
Nabumetone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.000676	CcSEcCtD
Nabumetone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000244	0.000675	CcSEcCtD
Nabumetone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.000675	CcSEcCtD
Nabumetone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.000673	CcSEcCtD
Nabumetone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.000673	CcSEcCtD
Nabumetone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.000672	CcSEcCtD
Nabumetone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.000672	CcSEcCtD
Nabumetone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.000669	CcSEcCtD
Nabumetone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000666	CcSEcCtD
Nabumetone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00024	0.000666	CcSEcCtD
Nabumetone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.000658	CcSEcCtD
Nabumetone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.000655	CcSEcCtD
Nabumetone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000653	CcSEcCtD
Nabumetone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.000653	CcSEcCtD
Nabumetone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000648	CcSEcCtD
Nabumetone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.000648	CcSEcCtD
Nabumetone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.000647	CcSEcCtD
Nabumetone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000644	CcSEcCtD
Nabumetone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000232	0.000644	CcSEcCtD
Nabumetone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.000643	CcSEcCtD
Nabumetone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000643	CcSEcCtD
Nabumetone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000642	CcSEcCtD
Nabumetone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.000638	CcSEcCtD
Nabumetone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.000638	CcSEcCtD
Nabumetone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.000637	CcSEcCtD
Nabumetone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000636	CcSEcCtD
Nabumetone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000229	0.000634	CcSEcCtD
Nabumetone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000629	CcSEcCtD
Nabumetone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.000628	CcSEcCtD
Nabumetone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000627	CcSEcCtD
Nabumetone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000625	CcSEcCtD
Nabumetone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000624	CcSEcCtD
Nabumetone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000623	CcSEcCtD
Nabumetone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000225	0.000622	CcSEcCtD
Nabumetone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000622	CcSEcCtD
Nabumetone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000622	CcSEcCtD
Nabumetone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000619	CcSEcCtD
Nabumetone—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.000618	CcSEcCtD
Nabumetone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00061	CcSEcCtD
Nabumetone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.000608	CcSEcCtD
Nabumetone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000602	CcSEcCtD
Nabumetone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000601	CcSEcCtD
Nabumetone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.000601	CcSEcCtD
Nabumetone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000598	CcSEcCtD
Nabumetone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000598	CcSEcCtD
Nabumetone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000216	0.000598	CcSEcCtD
Nabumetone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000595	CcSEcCtD
Nabumetone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000593	CcSEcCtD
Nabumetone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000593	CcSEcCtD
Nabumetone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000591	CcSEcCtD
Nabumetone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000213	0.000589	CcSEcCtD
Nabumetone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000588	CcSEcCtD
Nabumetone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000582	CcSEcCtD
Nabumetone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000579	CcSEcCtD
Nabumetone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000574	CcSEcCtD
Nabumetone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000571	CcSEcCtD
Nabumetone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000571	CcSEcCtD
Nabumetone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000565	CcSEcCtD
Nabumetone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000564	CcSEcCtD
Nabumetone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000562	CcSEcCtD
Nabumetone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00056	CcSEcCtD
Nabumetone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00056	CcSEcCtD
Nabumetone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000202	0.000559	CcSEcCtD
Nabumetone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000558	CcSEcCtD
Nabumetone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000557	CcSEcCtD
Nabumetone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000556	CcSEcCtD
Nabumetone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000543	CcSEcCtD
Nabumetone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000541	CcSEcCtD
Nabumetone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000538	CcSEcCtD
Nabumetone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000536	CcSEcCtD
Nabumetone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000536	CcSEcCtD
Nabumetone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000536	CcSEcCtD
Nabumetone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000533	CcSEcCtD
Nabumetone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000532	CcSEcCtD
Nabumetone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.000528	CcSEcCtD
Nabumetone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.00052	CcSEcCtD
Nabumetone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000518	CcSEcCtD
Nabumetone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000518	CcSEcCtD
Nabumetone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000511	CcSEcCtD
Nabumetone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000505	CcSEcCtD
Nabumetone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000501	CcSEcCtD
Nabumetone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.0005	CcSEcCtD
Nabumetone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000496	CcSEcCtD
Nabumetone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000495	CcSEcCtD
Nabumetone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000494	CcSEcCtD
Nabumetone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000493	CcSEcCtD
Nabumetone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000481	CcSEcCtD
Nabumetone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000478	CcSEcCtD
Nabumetone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000477	CcSEcCtD
Nabumetone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000477	CcSEcCtD
Nabumetone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000474	CcSEcCtD
Nabumetone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000467	CcSEcCtD
Nabumetone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000459	CcSEcCtD
Nabumetone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000455	CcSEcCtD
Nabumetone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000455	CcSEcCtD
Nabumetone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000452	CcSEcCtD
Nabumetone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.00045	CcSEcCtD
Nabumetone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000429	CcSEcCtD
